HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Bradshaw, D. A. Articles by Murphy, D. P. Search for Related Content PubMed PubMed Citation Articles by Bradshaw, D. A. Articles by Murphy, D. P.

An Oral Hypnotic Medication Does Not Improve Continuous Positive Airway Pressure Compliance in Men With Obstructive Sleep Apnea^*

^* From the Pulmonary Division, Department of Internal Medicine, Naval Medical Center San Diego, San Diego, CA.

Correspondence to: CAPT David A. Bradshaw, c/o Clinical Investigation Department (KCA), Naval Medical Center San Diego, 34800 Bob Wilson Dr, Suite 5, San Diego, CA 92134-1005; e-mail: DABradshaw{at}nmcsd.med.navy.mil

Abstract

Background: Compliance with continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) is highly variable. Recent studies suggest that the initial experience with CPAP may determine long-term success. We hypothesized that administration of a hypnotic medication to new CPAP users would facilitate acclimation and increase usage.

Methods: Seventy-two male OSA patients referred for CPAP treatment were randomized to also receive an oral hypnotic agent (zolpidem), placebo pill, or neither (standard care) for the first 14 days of CPAP treatment. CPAP usage (effective mask pressure [hours per day]) was recorded by an internal data chip. Patient symptoms were assessed with the Epworth sleepiness scale (ESS) and functional outcomes of sleep questionnaire (FOSQ). Treatment groups were matched for age, body mass index, and baseline ESS and FOSQ scores. Despite randomization, the standard care group had a higher apnea/hypopnea index than either the zolpidem or placebo pill groups (54.75 ± 28.02 vs 32.61 ± 25.12 vs 38.09 ± 25.65, p = 0.012) [mean ± SD]. Compared to placebo pill and standard care groups, the zolpidem group did not show greater CPAP usage in terms of total days used (zolpidem, 20.58 ± 7.40 days; placebo pill, 17.83 ± 9.33 days; standard care, 22.92 ± 6.95 days; p = 0.198) or average time used per night (4.43 ± 1.16 h vs 4.23 ± 2.14 h vs 4.94 ± 1.44 h, p = 0.361). All groups showed significant symptom improvements on both the ESS (p < 0.001) and FOSQ (p < 0.05).

Conclusion: Administration of an oral hypnotic agent did not improve initial CPAP compliance in men with OSA.

Key Words: compliance • continuous positive airway pressure • hypnotic • obstructive sleep apnea • zolpidem

This article has been cited by other articles:

				R. Pelayo and C. Guilleminault The Role of Hypnotics in Continuous Positive Airway Pressure Compliance Chest, May 1, 2007; 131(5): 1616 - 1616. [Full Text] [PDF]

eLetters: